• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket

    9/6/22 6:41:31 AM ET
    $AHI
    $ALNA
    $AMPE
    $AMRS
    Package Goods/Cosmetics
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHI alert in real time by email

    Gainers

    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) rose 25.1% to $2.89 in pre-market trading.
    • Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) shares rose 24% to $0.85 in pre-market trading after declining around 5% on Friday.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 16.7% to $1.08 in pre-market trading after climbing over 23% on Friday.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 15.1% to $1.68 in pre-market trading. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) rose 15% to $0.85 in pre-market trading. The company, last month, posted a proft for the second quarter.
    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 14.7% to $0.1138 in pre-market trading after gaining around 8% on Friday.
    • Ideanomics, Inc. (NASDAQ:IDEX) rose 13.7% to $0.69 in pre-market trading. Ideanomics posted a FY21 loss of $0.57 per share on sales of $114.08 million.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) rose 10.6% to $5.30 in pre-market trading. HIVE reported its August 2022 production figures and mining capacity.
    • Globalstar, Inc. (NASDAQ:GSAT) rose 9.8% to $2.24 in pre-market trading.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) rose 9.8% to $2.91 in pre-market trading after climbing around 27% on Friday.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) rose 9.2% to $0.3499 in pre-market trading after gaining around 5% on Friday.
    • ObsEva SA (NASDAQ:OBSV) rose 9% to $0.1811 in pre-market trading. ObsEva, last month, posted a Q2 loss of $0.39 per share.
    • Evogene Ltd. (NASDAQ:EVGN) rose 8.8% to $1.11 in pre-market trading. Evogene recently said Q2 revenue jumped 131% year-over-year.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 8.7% to $7.66 in pre-market trading after dropping 15% on Friday. The company, last week, priced its IPO at $6.125 per unit.
    • Tenax Therapeutics, Inc.(NASDAQ:TENX) rose 8.5% to $0.2239 in pre-market trading after declining 9% on Friday.
    • Amyris, Inc. (NASDAQ:AMRS) rose 7.3% to $2.93 in pre-market trading.
    • New Fortress Energy Inc. (NYSE:NFE) rose 6.2% to $59.00 in pre-market trading.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Creatd, Inc. (NASDAQ:CRTD) shares fell 28.1% to $0.2702 in pre-market trading after dipping 31% on Friday. Creatd received delist decision and received 15 days to file appeal.
    • Digital World Acquisition Corp (NASDAQ:DWAC) shares fell 18.8% to $20.30 in pre-market trading. Shareholders have rejected the special purpose acquisition company’s proposal to extend by a year the deadline for its merger with former President Donald Trump’s Trump Media & Technology, which operates the Truth Social platform, Reuters reported.
    • Kuke Music Holding Limited (NYSE:KUKE) fell 16.5% to $0.6850 in pre-market trading after dipping 27% on Friday.
    • Amesite Inc. (NASDAQ:AMST) fell 15.8% to $0.31 in pre-market trading. Amesite recently announced a $2.3 million registered direct offering.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 15.4% to $7.30 in pre-market trading. Raymond James recently downgraded the stock form Market Perform to Underperform.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 13.6% to $1.07 in pre-market trading after jumping 29% on Friday. Advanced Human Imaging, on Friday, entered into definitive agreement to acquire wellteq Digital Health Inc.
    • Burcon NutraScience Corporation (NASDAQ:BRCN) fell 12.6% to $0.4550 in pre-market trading as the company reported delisting from Nasdaq Capital Market on or about September 12. The company also announced auditor resignation and postponement of annual meeting of shareholders.
    • Boxlight Corporation (NASDAQ:BOXL) fell 10.6% to $0.59 in pre-market trading. Boxlight, last month, reported better-than-expected Q2 sales results.
    • PaxMedica, Inc. (NASDAQ:PXMD) fell 10.3% to $4.63 in pre-market trading following the company's recent IPO.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares fell 9.6% to $0.1943 in pre-market trading after gaining 13% on Friday.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) fell 9.3% to $0.0950 in pre-market trading.
    • Bright Green Corporation (NASDAQ:BGXX) fell 8.7% to $1.37 in pre-market trading.
    • Nine Energy Service, Inc. (NYSE:NINE) fell 6.8% to $2.99 in pre-market trading after gaining 5% on Friday.
    • Golden Ocean Group Limited (NASDAQ:GOGL) fell 5.6% to $8.70 in pre-market trading.
    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $ALNA
    $AMPE
    $AMRS

    CompanyDatePrice TargetRatingAnalyst
    HIVE Digital Technologies Ltd.
    $HIVE
    1/27/2026$3.50Outperform → Mkt Perform
    Keefe Bruyette
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Globalstar Inc.
    $GSAT
    12/16/2025$62.00Hold
    Deutsche Bank
    CytomX Therapeutics Inc.
    $CTMX
    9/22/2025$6.00Overweight
    Cantor Fitzgerald
    CytomX Therapeutics Inc.
    $CTMX
    9/17/2025$3.50Overweight
    Barclays
    New Fortress Energy Inc.
    $NFE
    9/8/2025$1.00Equal Weight → Underweight
    CapitalOne
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    New Fortress Energy Inc.
    $NFE
    8/13/2025$4.00Buy → Hold
    Johnson Rice
    More analyst ratings

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RETRANSMISSION: Independent Proxy Advisory Firms Recommend HIVE Shareholders Vote "FOR" All Resolutions

    Your vote is important – Vote well in advance of the proxy voting deadline: 11:00 a.m. (Pacific time) on March 3, 2026.Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting "INFO" to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).San Antonio, Texas--(Newsfile Corp. - February 20, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) ("HIVE") is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services ("ISS") have recommended shareholders vote "FOR" each of the resolutions

    2/20/26 6:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Independent Proxy Advisory Firms Recommend HIVE Shareholders Vote "FOR" All Resolutions

    Your vote is important – Vote well in advance of the proxy voting deadline: 11:00 a.m. (Pacific time) on March 3, 2026.Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting "INFO" to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).San Antonio, Texas--(Newsfile Corp. - February 20, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) ("HIVE") is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services ("ISS") have recommended shareholders vote "FOR" each of the resolutions

    2/20/26 1:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Globalstar, Inc. Earnings Release and Call Notice

    Globalstar, Inc. (NASDAQ:GSAT) will announce its fourth quarter and full year 2025 financial and operating results on Friday, February 27, 2026 before the market opens. The release will be available over the wire and from the Globalstar, Inc. website at www.globalstar.com. The Company will also conduct a conference call on Friday, February 27, 2026 at 9:00 a.m. Eastern Time (ET) to discuss these results. Details are as follows: Earnings Call: The earnings call will be available via webcast from the following link.   Webcast Link: https://edge.media-server.com/mmc/p/8v6dbgc2   To participate in the earnings call via teleconference, participants should register at t

    2/19/26 4:15:00 PM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HIVE Digital Technologies downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded HIVE Digital Technologies from Outperform to Mkt Perform and set a new price target of $3.50

    1/27/26 8:41:15 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Guggenheim initiated coverage on CytomX Therapeutics with a new price target

    Guggenheim initiated coverage of CytomX Therapeutics with a rating of Buy and set a new price target of $10.00

    1/20/26 9:23:09 AM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deutsche Bank initiated coverage on Globalstar with a new price target

    Deutsche Bank initiated coverage of Globalstar with a rating of Hold and set a new price target of $62.00

    12/16/25 9:28:16 AM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Rich Stuart bought $50,792 worth of shares (5,000 units at $10.16), increasing direct ownership by 90% to 5,266 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/10/25 6:48:57 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Rich Stuart bought $45,622 worth of shares (5,000 units at $9.12), increasing direct ownership by 940% to 2,766 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/5/25 5:46:32 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Giordano Christopher Thomas bought $20,000 worth of shares (2,605 units at $7.68) (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    11/20/25 6:38:51 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $ALNA
    $AMPE
    $AMRS
    SEC Filings

    View All

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    2/20/26 9:27:10 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    2/20/26 9:23:38 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Wheeler Real Estate Investment Trust Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    2/20/26 9:21:15 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Losh J Michael

    4 - Amesite Inc. (0001807166) (Issuer)

    2/10/26 5:18:58 PM ET
    $AMST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Omenn Gilbert S

    4 - Amesite Inc. (0001807166) (Issuer)

    2/10/26 5:17:58 PM ET
    $AMST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Parmer George

    4 - Amesite Inc. (0001807166) (Issuer)

    2/10/26 5:16:58 PM ET
    $AMST
    Computer Software: Prepackaged Software
    Technology

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Leadership Updates

    Live Leadership Updates

    View All

    Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

    The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann Institute of Science REHOVOT, Israel and MUNICH, Germany, Feb. 11, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, Systasy Bioscience GmbH, a biotechnology company leveraging proprietary DNA barcoding technology for hyper-multiplexed pathway profiling in patient-derived iPSC models to accelerate drug discovery for complex disorders, and LMU University Hospital Munich, today announced a collaboration aiming to accelerate the devel

    2/11/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

    Appointments Strengthen Scientific Leadership and Support the Acceleration of ChemPass AI™ for Drug and Ag-Chemical Discovery REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries, today announced the appointment of Prof. John J. Irwin of the University of California, San Francisco (UCSF), and Prof. Dan T. Major of Bar-Ilan University (BIU) to its scientific advisory board (SAB). The

    2/9/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    HIVE Digital Technologies Announces Filing and Mailing of Annual General and Special Meeting Materials

    Your vote is important - vote today.The Board of Directors unanimously recommends that Shareholders vote FOR the election of directors, appointment of auditors, amended incentive stock option plan, amended restricted share unit plan, and amendment to the shareholder quorum requirements at the annual general and special meeting.Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting "INFO" to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).San Antonio, Texas--(Newsfile Corp. - January 28, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE:

    1/28/26 6:31:00 PM ET
    $HIVE
    Finance: Consumer Services
    Finance

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Financials

    Live finance-specific insights

    View All

    Globalstar, Inc. Earnings Release and Call Notice

    Globalstar, Inc. (NASDAQ:GSAT) will announce its fourth quarter and full year 2025 financial and operating results on Friday, February 27, 2026 before the market opens. The release will be available over the wire and from the Globalstar, Inc. website at www.globalstar.com. The Company will also conduct a conference call on Friday, February 27, 2026 at 9:00 a.m. Eastern Time (ET) to discuss these results. Details are as follows: Earnings Call: The earnings call will be available via webcast from the following link.   Webcast Link: https://edge.media-server.com/mmc/p/8v6dbgc2   To participate in the earnings call via teleconference, participants should register at t

    2/19/26 4:15:00 PM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

    Zoom conference call scheduled for March 5, 2026, 9:00 AM ET REHOVOT, Israel, Feb. 19, 2026 /PRNewswire/ -- Evogene Ltd . (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the fourth quarter and full year 2025, on Thursday, March 5, 2026. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).To attend the conference, please register in advance: https://www.veidan-conferencing.com/evogene The entire conference will be

    2/19/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $ALNA
    $AMPE
    $AMRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care